FDA Approved:Yes (First approved January 30, 2015) Brand name:Glyxambi Generic name:empagliflozin and linagliptin Dosage form:Tablets Company:Boehringer Ingelheim Pharmaceuticals, Inc. Treatment for:Type 2 Diabetes Glyxambi(empagliflozin and linagliptin) is a sodium glucose co-transporter-2 (SGLT2) inhi...
Glyxambi Generic name:empagliflozin and linagliptin[EM-pa-gli-FLOE-zin-and-LIN-a-GLIP-tin] Drug class:Antidiabetic combinations Medically reviewed byPhilip Thornton, DipPharm. Last updated on Nov 13, 2024. Uses Warnings Before taking Dosage ...
Glyxambi Generic Name: empagliflozin and linagliptin tablets Brand Name: Glyxambi Drug Class: Antidiabetics, Dipeptyl Peptidase-IV Inhibitors, Antidiabetics, SGLT2 InhibitorsMedical Editor: John P. Cunha, DO, FACOEP Last updated on RxList: 11/16/2023 home drugs a-z list glyxambi (...
Common Generic Name(s):empagliflozin/linagliptin Pronunciation:glik-SAM-bee Drug Classes:antidiabetic, sodium-glucose co-transporter 2 (SGLT2) inhibitor, dipeptidyl peptidase-4 (DPP-4) inhibitor Availability:prescription only, no generic available ...
Glyxambi (empagliflozin/linagliptin) - Uses, Side Effects, and More Medically Reviewed by Cerris Chung, PharmD, BCACP on Jul 21, 2024 | Written by Beth Johnston, PharmD, BCPS Common Brand Name(s): Glyxambi Common Generic Name(s): empagliflozin/linagliptin Pronunciation: glik-SAM-bee Drug Cl...